Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia
Andrea L Schaffer, Nicholas A Buckley, Louisa Degenhardt, Briony Larance, Rose Cairns, Timothy A Dobbins, Sallie-Anne Pearson
Canadian Medical Association Journal | CMA-CANADIAN MEDICAL ASSOC | Published : 2018
Awarded by National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Medicines and Ageing
Awarded by NHMRC
This research is supported, in part, by the National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Medicines and Ageing (ID 1060407). Andrea Schaffer, Briony Larance and Louisa Degenhardt are supported by the NHMRC (IDs 1074924, 1041472, 1073858). The National Drug and Alcohol Research Centre at the University of New South Wales is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. The study funders were not involved in the study. All of the authors performed the research independent of the funders.